Lipoproteins/Particles

Slides:



Advertisements
Similar presentations
Lipoprotein Structure, Function, and Metabolism
Advertisements

Lipoprotein Metabolism And Disorders
COMPOSITION OF LIPIDS Lipoproteins Apolipoproteins Lipoproteins Apolipoproteins Cholesterol Protein Triglyceride Phospholipid.
Genetic Factors of Coronary Artery Disease Risk
بسم الله الرحمن الرحيم.
Friend or Foe? High HDL Cholesterol. High Density Lipoprotein Origin: liver Content: 18-25% TC content 45-55% Protein 2-7% TG 20-30% Phospholipids Density:
Lipoprotein Structures, Function and Metabolism (1)
HDL Particles but not LDL Particles Predict Cardiovascular Disease Events in HIV Patients: Results from Strategies for Management of ART Study (SMART)
Lipoprotein Structure and Function
Cholesterol sources, biosynthesis and degradation  diet  only found in animal fat  biosynthesis  primarily synthesized in the liver from acetyl CoA.
Lipoproteins Metabolism
THE LIPID PANEL What are we missing? Robert St. Amant, MD, FAAFP Diplomate, American Board of Clinical Lipidology Baton Rouge General Medical Director,
Lipoproteins Clusters of lipids associated with proteins that serve as transport vehicles for lipids in the lymph and blood.
Aims 1.Outline the structural diversity of lipids. 2.Examine the biophysical characteristics of lipids. 3Outline the biochemical synthesis of fatty acids,
 The third major class of lipids  The three cyclohexane rings (A, B, C) are connected to a cyclopentane ring (D).  Significantly different structure.
1 LIPID TRANSPORT Lipoproteins Lipids are transported in the blood as lipoproteins are soluble in water because the surface consists of polar lipids.
Hyperlipidaemia. History  Hypercholestrolemia is an inherited condition and for several years scientists have studied the effects of high cholesterol.
Cholesterol exogenous (dietary) cholesterol delivered to
Lipoprotein Structures, Function and Metabolism (2)
13.9 Cholesterol.
ECDA September LIPID DIGESTION  Lipids in the diet are most commonly triglycerides or neutral fats found in both animals and plants. Cholesterols.
بسم الله الرحمن الرحيم.
بسم الله الرحمن الرحيم.
Kristin Miller Caleb Conrad 13.9 What Are Steroids.
L IPOPROTEINS. W HAT ARE LIPOPROTEINS ? Lipoproteins are molecules produced in the body and act as lipid transporters They consist of: Triglycerides Protein.
Lipoprotein Structure and Function LP core Triglycerides Cholesterol esters LP surface Phospholipids Proteins Cholesterol Are conjugated proteins, composed.
Size and apolipoprotein composition are the main factors determining atherogenicity of triglyceride-rich particles.
Lipid profiles in Cardio Vascular Diseases. What is a lipid profile? The lipid profile is a group of tests that are often ordered together to determine.
Lipoproteins A lipoprotein is a biochemical assembly that contains both proteins and lipids, bound to the proteins, which allow fats to move through the.
Lab (6): Lipids profile KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab (Bioc 416) 2012 T.A Nouf Alshareef
Nordestgaard et al. EAS EFLM joint Consensus Panel. Eur Heart J 2016; online April 26.
Lipids in the diet are hydrolyzed in the small intestine, and the resultant fatty acids and monoglycerides are repackaged with apoB-48 into TG-enriched.
Lipoprotein Structure, Function, and Metabolism
Apolipoproteins.
Lipoproteins and Atheroscloresis
Lipoproteins and Atheroscloresis
Arabinda Mohan Bhattarai, MBBS, MD (Biochemistry) Asst Prof, NAIHS
Director, Lipid Research Center The Johns Hopkins Medical Institutions
What Lipoprotein Related Parameters Should Be Measured And How Should They Be Treated in Dyslipidemic Patients with Cardiovascular Disease? Peter O Kwiterovich,
HDL Particle Number Is It a Key to Understanding HDL Cardiovascular Risk and Therapy? Jim Otvos, PhD Chief Scientific Officer LipoScience, Inc. Adjunct.
Atherosclerosis, Plaque Imaging
Plasma LIPOPROTEINS METABOLISM & DISORDERS Basil OM Saleh
LIPIDS AND LIPOPROTEINS Dr. Gamal Gabr
Biogenesis of Nascent High Density Lipoprotein Particles
Review of Cholesterol and Lipoproteins
Figure 7 Mendelian randomization of overlapping exposures
Biogenesis of Nascent High Density Lipoprotein Particles
Charles R. Harper, MD, Terry A. Jacobson, MD  Mayo Clinic Proceedings 
Cholesterol and Lipoproteins
Charles R. Harper, MD, Terry A. Jacobson, MD  Mayo Clinic Proceedings 
Effect of evolocumab on lipoprotein particles
Figure 1 Overview of lipoprotein metabolism and effects of novel lipid-modulating approaches Figure 1 | Overview of lipoprotein metabolism and effects.
Sebelipase alfa improves atherogenic biomarkers in adults and children with lysosomal acid lipase deficiency  Don P. Wilson, MD, FNLA, Mark Friedman,
HCV and the hepatic lipid pathway as a potential treatment target
Lipoproteins and cholesterol
HDL and Atherosclerosis
II. assessment of dyslipidemias
APOC3, Coronary Disease, and Complexities of Mendelian Randomization
Dual Role of Circulating Angiopoietin-Like 4 (ANGPTL4) in Promoting Hypertriglyceridemia and Lowering Proteinuria in Nephrotic Syndrome  Nosratola D.
Mikko Syvänne, MD, Marja-Riitta Taskinen, MD  The Lancet 
If triglycerides matter, why do they matter?
To B or Not to B: Is Non–High-Density Lipoprotein Cholesterol an Adequate Surrogate for Apolipoprotein B?  Carl J. Lavie, MD, Richard V. Milani, MD, James.
Cholesterol.
Figure 1 The major pathways of lipid metabolism
Body mass, BMI, plasma lipids, lipoproteins, and glucose homeostasis at baseline, and following placebo and rosuvastatin periods Dmitri Sviridov et al.
Influence of low-glucose peritoneal dialysis on serum lipids and apolipoproteins in the IMPENDIA/EDEN trials  Allan D. Sniderman, MD, James A. Sloand,
Assembly and secretion of apoB100- containing lipoproteins
(A) Low-density lipoprotein-cholesterol (LDL-C) values at baseline and after treatment with anagliptin in 20 participants at 12 and 24 weeks. (A) Low-density.
ABSORPTION.
Individual lipid measures for high-carbohydrate (n=10) and low-carbohydrate (n=10) ultra-endurance athletes. Individual lipid measures for high-carbohydrate.
Presentation transcript:

Lipoproteins/Particles ApoA1 ApoB TG Rich Chylomicron VLDL 0.95 Chylomicron Remnants VLDL Remnants 1.006 IDL Density (g/ml) LDL-R 1.019 By reporting single values for lipoprotein cholesterol levels, the traditional lipid panel implies that lipoproteins such as HDL, LDL,… are single entities. This slide illustrates that all lipid sub-fractions are present in a continuum of size and density, with an especially large gradient for the triglyceride-rich lipoproteins IDL, VLDL, and chylomicrons. Technologies that sort by particle size (NMR and GGE) cannot separate IDL and Lp(a) from LDL-R, as these particles have overlapping size. They do differ by density so ultracentrifugation is the best way to separate total LDL into its 3 components. Total LDL is made up of Lp(a), IDL and real LDL or R-LDL-R. We define R-LDL as total LDL-C minus Lp(a)-C minus IDL-C. Each requires different therapies, confers different risk and has different inheritance. Both Lp(a) and IDL are more atherogenic than LDL itself. They do not respond to statins and both are highly inherited and implicated in premature CAD. Lp(a), “the widowmaker” doubles risk but when another lipid risk factor, such as dense LDL, is also present the risk leaps to 25x. It may be useful to point out that Lp(a) cannot be accurately measured in most commercial laboratories because the immunoassay kits are sensitive to the size heterogeneity of the apoprotein(a) due to variation in the # of kringle repeats. Lp(a) rises in renal failure and is probably partly responsible for the terrible CAD in ESRD patients. High IDL requires combination therapy with a statin plus niacin. Density 1.006-1.019 g/ml. Lp(a) and R-LDL are density range 1.019-1.063 g/ml. Lp(a) and small/dense LDL overlap in the density range 1.050-1.063 g/ml. Note that Lp(a) has overlaps with IDL and large R-LDL when GGE is used because of its different electrophoretic mobility – while the actual Lp(a) size is 21nm-25nm. Dense, small LDL is called Pattern B and increases risk 4x. Intermediately dense LDL is called Pattern A/B and doubles risk. HDL2 is the most protective HDL sub-fraction. HDL3 may be mildly protective to inert. You may have normal HDL but still have low HDL2 and not know it. Exercise and wine raise HDL2, as does niacin, fenofibrate and simvastatin. Atherogenic remnant lipoproteins include IDL and VLDL3 (small/dense). These are elevated in Metabolic Syndrome and NIDDM, and respond to low carbohydrate diets. If Lp(a), IDL or small/dense LDL pattern B are found, then first degree relatives should be tested. Note that large LDL may be confused with Lp(a) and IDL with size-based (vs. density based) separation methods as Lp(a) and IDL overlap with large R-LDL in size. 1.050 1.063 HDL2 Lp(a) Only these lipoprotein particles found in plaque at biopsy. 1.100 HDL3 1.20 1000 5 10 20 40 60 80 Lipoprotein/Particle Size (nm)

What is Total Cholesterol…Really VLDL3: Most dense VLDL subclass. Atherogenic B Total VLDL: Main carrier of triglycerides. Elevated levels shown to contribute to increased risk for CAD. VLDL-C Buoyant LDL Pattern A: Large, buoyant LDL B B IDL Remnants IDL: An intermediate in VLDL catabolism. Atherogenic B Dense LDL Pattern B: Small, dense LDL. “Highest Risk” Total LDL: The end product of VLDL catabolism. LDL-C TG-RICH LIPOPROTEINS HDL2 HDL2:Large, buoyant HDL. A B Lp(a): Consists of LDL plus a protein called apo(a). “Heart attack” cholesterol. Total HDL HDL-C HDL3 HDL3: Small, Less mature A ApoA lipoproteins ApoB lipoproteins (Bad – NHDLc = VLDL, IDL, LDL, Lpa-c)

Lipoprotein Particles by Density and Size Segrest et al. Atlas of Atherosclerosis. 2nd Edition; Philadephia